| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,588,016 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$13,588,016 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CLO |
• – – |
2016-01-04 |
4 |
A |
$0.01 |
$138 |
D/D |
13,800 |
13,800 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,204 |
28,554 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$1,743,469 |
D/D |
(10,829) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-07-19 |
4 |
OE |
$86.52 |
$968,970 |
D/D |
10,829 |
39,638 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-08-03 |
4 |
AS |
$155.72 |
$362,828 |
D/D |
(2,330) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-08-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
31,139 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-10-12 |
4 |
AS |
$152.93 |
$324,976 |
D/D |
(2,125) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-10-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
30,934 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-11-03 |
4 |
AS |
$149.50 |
$348,335 |
D/D |
(2,330) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-11-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
31,139 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-01-12 |
4 |
AS |
$157.16 |
$333,965 |
D/D |
(2,125) |
28,943 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-01-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
31,068 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-01 |
4 |
AS |
$174.11 |
$600,680 |
D/D |
(3,450) |
25,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-05 |
4 |
AS |
$163.08 |
$379,976 |
D/D |
(2,330) |
25,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-05 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
27,823 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,641 |
52,134 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-12 |
4 |
AS |
$153.41 |
$1,861,784 |
D/D |
(12,136) |
39,998 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-25 |
4 |
AS |
$155.07 |
$390,233 |
D/D |
(2,514) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-25 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
42,123 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-26 |
4 |
AS |
$159.56 |
$6,103,170 |
D/D |
(38,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-26 |
4 |
OE |
$122.45 |
$4,683,713 |
D/D |
38,250 |
77,859 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-05-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
41,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-05-03 |
4 |
AS |
$149.50 |
$348,335 |
D/D |
(2,330) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$13,241 |
D/D |
(85) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-05 |
4 |
AS |
$168.38 |
$715,615 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
115 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
